查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1734852

2032年药用玻璃管市场预测：按玻璃类型、製造流程、形状、分销管道、应用、最终用户和地区进行的全球分析

Pharmaceutical Glass Tubing Market Forecasts to 2032 - Global Analysis By Glass Type (Borosilicate Glass, Soda-Lime Glass, and Other Glass Types), Manufacturing Process, Form, Distribution Channel, Application, End Users and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的预测，全球药用玻璃管市场规模预计在 2025 年达到 160.9 亿美元，到 2032 年将达到 240.4 亿美元，预测期内的复合年增长率为 5.9%。

药用玻璃管是一种用于製造储存和分配药品容器的特殊玻璃。它主要由硼硅酸玻璃或钠钙玻璃製成，具有很高的耐化学性、热稳定性和耐用性。这种玻璃透过防止药物与容器发生相互作用，确保了药物的纯度和安全性。它常用于製药和生物技术行业，用于製造管瓶、安瓿瓶和注射器。

增加医疗基础建设投资

对优质医药包装日益增长的需求，推动了全球医疗基础设施的投资。各国政府和私营机构正致力于改善药物储存和输送系统，以确保安全性和有效性。先进的药用玻璃管因其卓越的耐化学性和极低的污染风险而备受青睐。玻璃管材料的创新提高了耐用性，并支持高效的给药方法。此外，慢性病发生率的上升也刺激了改善医疗包装解决方案的投资。

玻璃脱层风险

玻璃脱层是管瓶内表面薄层剥落的现象，对药品包装构成了重大挑战。这一问题可能会损害药物稳定性，并导致患者健康风险。製造商必须实施严格的品管措施来降低这些风险，但这会增加生产成本。此外，在不同配方中保持一致的玻璃品质也十分复杂，限制市场的发展。

严格的药品安全监理标准

遵守这些标准可实现高品质、无污染的包装，从而推动对先进玻璃管解决方案的需求。特种涂层和改进的玻璃成分使製药公司能够满足严格的安全要求。生技药品和注射剂的日益增长的关注推动了对可靠耐用玻璃管的需求。那些投资研发以提高产品完整性的公司正在市场上获得竞争优势。

有限的回收和永续性挑战

特种玻璃成分复杂，难以回收，引发环境担忧。製造商正在探索环保替代品，但成本和技术障碍阻碍了其推广应用。此外，药用玻璃废弃物的处理必须遵循严格的规范，这进一步加剧了永续性的复杂性。开发商面临开发更环保解决方案的压力，同时需要保持产品功效并符合法规要求。

COVID-19的影响

新冠疫情对药用玻璃管市场产生了重大影响，既有正面的一面，也有负面的一面。疫苗包装需求的增加导致玻璃管产量激增，从而推动了市场成长。然而，供应链中断和原材料短缺导致生产和分销延误。疫情凸显了可靠的药品包装对药品稳定性和安全性的重要性。自疫情爆发以来，企业一直致力于提高生产效率，以应对未来的医疗危机。

透明管市场预计将成为预测期内最大的市场

由于其透明度和化学稳定性，透明管预计将在预测期内占据最大的市场占有率。透明管有助于药物检测，确保注射药物的品管和安全。透明管受到製造商的青睐，因为它们与各种製剂相容，并降低了污染风险。生物製药和疫苗的日益普及也推动了该领域的需求。

预测期内，医院和诊断中心部门将见证最高的复合年增长率。

预计医院和诊断中心细分市场将在预测期内实现最高成长率，这得益于医疗机构和诊断实验室数量的不断增加，从而推动了对可靠医药包装解决方案的需求。精准医疗等医疗技术的进步需要高品质的玻璃管用于药物传输。对病人安全和药物疗效的日益关注进一步刺激了该细分市场的需求。此外，医院扩建和政府医疗保健措施也支持了市场的持续成长。

比最大的地区

在预测期内，亚太地区预计将占据最大的市场占有率，这得益于其强大的医疗基础设施和不断增长的药品产量。中国、印度和日本等国家已成为药品製造和包装创新领域的主要参与者。政府鼓励医疗保健进步的政策正在推动该地区市场的成长。领先的药用玻璃管製造商的存在提高了供应链效率并降低了价格。

复合年增长率最高的地区：

受严格的监管标准和技术进步的推动，北美地区预计将在预测期内呈现最高的复合年增长率。生技药品和注射剂的日益增长的关注推动了对优质玻璃管材料的需求。美国和加拿大的製药公司正在大力投资创新包装解决方案，以提高药物稳定性。不断增长的医疗保健支出和严格的药品安全要求进一步推动了市场扩张。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球药用玻璃管市场（以玻璃类型）

  • 硼硼硅酸玻璃（I型）
  • 钠钙玻璃（II 型和 III 型）
  • 其他玻璃类型

6. 全球药用玻璃管市场（依製造流程）

  • 模压玻璃管
  • 管状玻璃管

7. 全球药用玻璃管市场类型

  • 透明管
  • 彩色管
  • 霜管
  • 其他形状

8. 全球药用玻璃管市场（依分销管道）

  • 直销
  • 经销商
  • 线上管道

第九章全球药用玻璃管市场（按应用）

  • 管瓶
  • 安瓿
  • 墨水匣
  • 注射器
  • 试管
  • 瓶子
  • 其他用途

第十章 全球药用玻璃管市场（依最终用户）

  • 製药商
  • 契约製造组织（CMO）
  • 生技公司
  • 医院和诊断中心
  • 研发实验室
  • 其他最终用户

第11章全球药用玻璃管市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司概况

  • Schott AG
  • Gerresheimer AG
  • Nipro Corporation
  • SGD Pharma
  • Stevanato Group SpA
  • West Pharmaceutical Services, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Ardagh Group SA
  • Bormioli Pharma SpA
  • Piramal Glass Private Limited
  • Shandong Weigao Group Medical Polymer Products Co., Ltd.
  • Nihon Yamamura Glass Co., Ltd.
  • Amino GmbH
  • Richland Glass Company, Inc.
Product Code: SMRC29489

According to Stratistics MRC, the Global Pharmaceutical Glass Tubing Market is accounted for $16.09 billion in 2025 and is expected to reach $24.04 billion by 2032 growing at a CAGR of 5.9% during the forecast period. Pharmaceutical glass tubing is a specialized type of glass used in the production of containers for storing and delivering medications. Made primarily from borosilicate or soda-lime glass, it offers high chemical resistance, thermal stability, and durability. This glass ensures the purity and safety of pharmaceutical products by preventing interactions with the container. It is commonly used to manufacture vials, ampoules, and syringes in the pharmaceutical and biotechnology industries.

Market Dynamics:

Driver:

Rising investment in healthcare infrastructure

The increasing demand for high-quality pharmaceutical packaging is driving investment in healthcare infrastructure globally. Governments and private entities are focusing on improving drug storage and delivery systems to ensure safety and efficacy. Advanced pharmaceutical glass tubing provides superior chemical resistance and minimizes contamination risks, making it a preferred choice. Technological innovations in tubing materials enhance durability and support efficient drug administration methods. Additionally, the rising prevalence of chronic diseases is fuelling investments in improved medical packaging solutions.

Restraint:

Risk of glass delamination

Glass delamination, a phenomenon where thin layers peel away from the internal surface of a vial, poses a significant challenge to pharmaceutical packaging. This issue can lead to compromised drug stability and potential health risks for patients. Manufacturers must implement rigorous quality control measures to mitigate these risks, increasing production costs. Additionally, the complexity of maintaining consistent glass quality across different formulations adds to the restraint in market expansion.

Opportunity:

Stringent regulatory standards for drug safety

Compliance with these standards ensures high-quality, contamination-free packaging driving demand for advanced glass tubing solutions. Specialized coatings and improved glass compositions help pharmaceutical companies meet stringent safety requirements. As the focus on biologics and injectable drugs grows, the need for reliable and durable glass tubing rises. Companies investing in research and development to enhance product integrity are gaining a competitive edge in the market.

Threat:

Limited recycling and sustainability challenges

The complex composition of specialty glass makes recycling difficult, leading to environmental concerns. Manufacturers are exploring eco-friendly alternatives, but adoption remains slow due to cost and technical barriers. Additionally, the disposal of pharmaceutical glass waste must adhere to strict guidelines, further complicating sustainability efforts. Companies are under pressure to develop greener solutions while maintaining product efficacy and regulatory compliance.

Covid-19 Impact

The COVID-19 pandemic significantly influenced the pharmaceutical glass tubing market, both positively and negatively. Increased demand for vaccine packaging led to a surge in glass tubing production, boosting market growth. However, supply chain disruptions and raw material shortages caused delays in manufacturing and distribution. The pandemic underscored the importance of reliable pharmaceutical packaging for drug stability and safety. Companies have since focused on enhancing production efficiency to meet future healthcare crises.

The clear tubing segment is expected to be the largest during the forecast period

The clear tubing segment is expected to account for the largest market share during the forecast period, due to its transparency and chemical stability. Clear tubing facilitates easy drug inspection, ensuring quality control and safety for injectable medicines. Manufacturers prefer clear tubing for its compatibility with various formulations, reducing contamination risks. The growing adoption of biologic drugs and vaccines is further propelling demand for this segment.

The hospital & diagnostic centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospital & diagnostic centers segment is predicted to witness the highest growth rate, due to the increasing number of healthcare facilities and diagnostic labs is driving the need for reliable drug packaging solutions. Advancements in medical treatments, including precision therapies, require high-quality glass tubing for drug delivery. The emphasis on patient safety and drug efficacy further strengthens demand within this segment. Additionally, hospital expansions and government healthcare initiatives support sustained market growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share driven by robust healthcare infrastructure and rising pharmaceutical production. Countries like China, India, and Japan have established themselves as key players in drug manufacturing and packaging innovation. Government policies promoting healthcare advancements are fuelling market growth across the region. The presence of leading pharmaceutical glass tubing manufacturers enhances supply chain efficiency and affordability.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, propelled by strict regulatory standards and technological advancements. The growing focus on biologics and injectable drugs is driving demand for superior glass tubing materials. Pharmaceutical companies in the U.S. and Canada are heavily investing in innovative packaging solutions to enhance drug stability. Rising healthcare expenditure and stringent drug safety requirements further accelerate market expansion.

Key players in the market

Some of the key players profiled in the Pharmaceutical Glass Tubing Market include Schott AG, Gerresheimer AG, Nipro Corporation, SGD Pharma, Stevanato Group S.p.A., West Pharmaceutical Services, Inc., Corning Incorporated, DWK Life Sciences GmbH, Ardagh Group S.A., Bormioli Pharma S.p.A., Piramal Glass Private Limited, Shandong Weigao Group Medical Polymer Products Co., Ltd., Nihon Yamamura Glass Co., Ltd., Amino GmbH, and Richland Glass Company, Inc.

Key Developments:

In May 2025, SCHOTT Pharma, announced that TPG, a leading global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in its joint venture SCHOTT Poonawalla from Serum Institute of India (SII). SCHOTT Poonawalla is a joint venture of SCHOTT Pharma and SII, part of the Cyrus Poonawalla Group and a global leader in vaccine manufacturing, dedicated to providing affordable vaccines worldwide.

In November 2024, SGD Pharma expands capacity of siliconized glass vials with the announcement of a new siliconization line at its Center of Excellence for Type I glass in France. The company enhances its already extensive range of in-house services by internalizing its glass siliconization offer, further ensuring responsiveness, security of supply and improved flexibility of vial sizes.

Glass Types Covered:

  • Borosilicate Glass (Type I)
  • Soda-Lime Glass (Types II & III)
  • Other Glass Types

Manufacturing Processes Covered:

  • Molded Glass Tubing
  • Tubular Glass Tubing

Forms Covered:

  • Clear Tubing
  • Colored Tubing
  • Frosted Tubing
  • Other Forms

Distribution Channels Covered:

  • Direct Sales
  • Distributors
  • Online Channels

Applications Covered:

  • Vials
  • Ampoules
  • Cartridges
  • Syringes
  • Test Tubes
  • Bottles
  • Other Applications

End Users Covered:

  • Pharmaceutical Manufacturers
  • Contract Manufacturing Organizations (CMOs)
  • Biotechnology Companies
  • Hospital & Diagnostic Centers
  • Research & Development Labs
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Glass Tubing Market, By Glass Type

  • 5.1 Introduction
  • 5.2 Borosilicate Glass (Type I)
  • 5.3 Soda-Lime Glass (Types II & III)
  • 5.4 Other Glass Types

6 Global Pharmaceutical Glass Tubing Market, By Manufacturing Process

  • 6.1 Introduction
  • 6.2 Molded Glass Tubing
  • 6.3 Tubular Glass Tubing

7 Global Pharmaceutical Glass Tubing Market, By Form

  • 7.1 Introduction
  • 7.2 Clear Tubing
  • 7.3 Colored Tubing
  • 7.4 Frosted Tubing
  • 7.5 Other Forms

8 Global Pharmaceutical Glass Tubing Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Direct Sales
  • 8.3 Distributors
  • 8.4 Online Channels

9 Global Pharmaceutical Glass Tubing Market, By Application

  • 9.1 Introduction
  • 9.2 Vials
  • 9.3 Ampoules
  • 9.4 Cartridges
  • 9.5 Syringes
  • 9.6 Test Tubes
  • 9.7 Bottles
  • 9.8 Other Applications

10 Global Pharmaceutical Glass Tubing Market, By End User

  • 10.1 Introduction
  • 10.2 Pharmaceutical Manufacturers
  • 10.3 Contract Manufacturing Organizations (CMOs)
  • 10.4 Biotechnology Companies
  • 10.5 Hospital & Diagnostic Centers
  • 10.6 Research & Development Labs
  • 10.7 Other End Users

11 Global Pharmaceutical Glass Tubing Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Schott AG
  • 13.2 Gerresheimer AG
  • 13.3 Nipro Corporation
  • 13.4 SGD Pharma
  • 13.5 Stevanato Group S.p.A.
  • 13.6 West Pharmaceutical Services, Inc.
  • 13.7 Corning Incorporated
  • 13.8 DWK Life Sciences GmbH
  • 13.9 Ardagh Group S.A.
  • 13.10 Bormioli Pharma S.p.A.
  • 13.11 Piramal Glass Private Limited
  • 13.12 Shandong Weigao Group Medical Polymer Products Co., Ltd.
  • 13.13 Nihon Yamamura Glass Co., Ltd.
  • 13.14 Amino GmbH
  • 13.15 Richland Glass Company, Inc.

List of Tables

  • Table 1 Global Pharmaceutical Glass Tubing Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Pharmaceutical Glass Tubing Market Outlook, By Glass Type (2024-2032) ($MN)
  • Table 3 Global Pharmaceutical Glass Tubing Market Outlook, By Borosilicate Glass (Type I) (2024-2032) ($MN)
  • Table 4 Global Pharmaceutical Glass Tubing Market Outlook, By Soda-Lime Glass (Types II & III) (2024-2032) ($MN)
  • Table 5 Global Pharmaceutical Glass Tubing Market Outlook, By Other Glass Types (2024-2032) ($MN)
  • Table 6 Global Pharmaceutical Glass Tubing Market Outlook, By Manufacturing Process (2024-2032) ($MN)
  • Table 7 Global Pharmaceutical Glass Tubing Market Outlook, By Molded Glass Tubing (2024-2032) ($MN)
  • Table 8 Global Pharmaceutical Glass Tubing Market Outlook, By Tubular Glass Tubing (2024-2032) ($MN)
  • Table 9 Global Pharmaceutical Glass Tubing Market Outlook, By Form (2024-2032) ($MN)
  • Table 10 Global Pharmaceutical Glass Tubing Market Outlook, By Clear Tubing (2024-2032) ($MN)
  • Table 11 Global Pharmaceutical Glass Tubing Market Outlook, By Colored Tubing (2024-2032) ($MN)
  • Table 12 Global Pharmaceutical Glass Tubing Market Outlook, By Frosted Tubing (2024-2032) ($MN)
  • Table 13 Global Pharmaceutical Glass Tubing Market Outlook, By Other Forms (2024-2032) ($MN)
  • Table 14 Global Pharmaceutical Glass Tubing Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 15 Global Pharmaceutical Glass Tubing Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 16 Global Pharmaceutical Glass Tubing Market Outlook, By Distributors (2024-2032) ($MN)
  • Table 17 Global Pharmaceutical Glass Tubing Market Outlook, By Online Channels (2024-2032) ($MN)
  • Table 18 Global Pharmaceutical Glass Tubing Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Pharmaceutical Glass Tubing Market Outlook, By Vials (2024-2032) ($MN)
  • Table 20 Global Pharmaceutical Glass Tubing Market Outlook, By Ampoules (2024-2032) ($MN)
  • Table 21 Global Pharmaceutical Glass Tubing Market Outlook, By Cartridges (2024-2032) ($MN)
  • Table 22 Global Pharmaceutical Glass Tubing Market Outlook, By Syringes (2024-2032) ($MN)
  • Table 23 Global Pharmaceutical Glass Tubing Market Outlook, By Test Tubes (2024-2032) ($MN)
  • Table 24 Global Pharmaceutical Glass Tubing Market Outlook, By Bottles (2024-2032) ($MN)
  • Table 25 Global Pharmaceutical Glass Tubing Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 26 Global Pharmaceutical Glass Tubing Market Outlook, By End User (2024-2032) ($MN)
  • Table 27 Global Pharmaceutical Glass Tubing Market Outlook, By Pharmaceutical Manufacturers (2024-2032) ($MN)
  • Table 28 Global Pharmaceutical Glass Tubing Market Outlook, By Contract Manufacturing Organizations (CMOs) (2024-2032) ($MN)
  • Table 29 Global Pharmaceutical Glass Tubing Market Outlook, By Biotechnology Companies (2024-2032) ($MN)
  • Table 30 Global Pharmaceutical Glass Tubing Market Outlook, By Hospital & Diagnostic Centers (2024-2032) ($MN)
  • Table 31 Global Pharmaceutical Glass Tubing Market Outlook, By Research & Development Labs (2024-2032) ($MN)
  • Table 32 Global Pharmaceutical Glass Tubing Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.